Ramos-Montoya et al. [87] reported that HES6 had a driving role in androgen-independence acquisition by activating AR-independent pathways for sustaining the survival of PCa cells treated with anti-androgen therapies. This evidence concerns the gene HES6 and posterior cortical atrophy.